Skip to main content

Research Repository

Advanced Search

Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTs.

Iannaccone, Mario; Franchin, Luca; Russo, Filippo; Botti, Giulia; Castellano, Davide; Montorfano, Matteo; Boccuzzi, Giacomo; Mamas, Mamas A; Chieffo, Alaide

Authors

Mario Iannaccone

Luca Franchin

Filippo Russo

Giulia Botti

Davide Castellano

Matteo Montorfano

Giacomo Boccuzzi

Alaide Chieffo



Abstract

Pulmonary embolism (PE) represents one of the leading causes of death worldwide and mainly treated with medical management, although the utility of more invasive approaches has emerged more recently. This meta-analysis aims to evaluate the 30-day mortality of intermediate-to-high risk PE across different treatment strategies. A systematic literature review and meta-analysis was conducted using PubMed and Cochrane databases. All studies reporting 30-day mortality rates in intermediate-to-high-risk PE were included. Meta-regression analysis and sensitivity analysis were performed on the primary endpoint, 30-day mortality, and secondary endpoints (RV/LV ratio, mPAP, and long-term mortality, any bleeding events). Of the 2390 studies published between 2000 and 2022, 76 studies (74 observational and 2 RCTs for a total of 1,194,285 patients in the medical cohort and 3007 in the interventional cohort) were included. The median age was 71.4 (IQR 62.8-77.3) years, 53.6% were women. 30-day mortality in the patients treated with medical management was 9.1% (6.6-12.6). In the interventional cohort, 30-day mortality was 2.1% (1.5-3.1) while the pre- vs post-procedure change in mean difference was -6.1 mmHg (-11.2 to -1.1) for mPAP and - 0.41 (-0.51 to - 0.31) for RV/LV ratio. The overall bleeding rate in the interventional cohort was 4.9% (CI 2.6-8.9), without differences between the two strategies (RR 1.26 CI 0.89-1.78). Intermediate-high-risk mortality in pulmonary embolisms treated with medical management remains high in the modern era. Despite the absence of comparative studies, an interventional approach may have a lower 30-day mortality rate and a good safety profile. [Abstract copyright: Copyright © 2023 Elsevier B.V. All rights reserved.]

Citation

Iannaccone, M., Franchin, L., Russo, F., Botti, G., Castellano, D., Montorfano, M., …Chieffo, A. (2023). Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTs. International Journal of Cardiology, 387, Article 131127. https://doi.org/10.1016/j.ijcard.2023.131127

Journal Article Type Article
Acceptance Date Jun 19, 2023
Online Publication Date Jun 22, 2023
Publication Date Sep 15, 2023
Deposit Date Aug 7, 2023
Journal International journal of cardiology
Print ISSN 0167-5273
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 387
Article Number 131127
DOI https://doi.org/10.1016/j.ijcard.2023.131127
Keywords Pulmonary embolism, thrombus aspiration, meta-analysis, Thrombolysis
Publisher URL https://www.sciencedirect.com/science/article/pii/S0167527323009348?via%3Dihub